The effect of physical activity and body mass index on menopausal symptoms in Turkish women: a cross-sectional study in primary care by unknown
Tan et al. BMC Women's Health 2014, 14:38
http://www.biomedcentral.com/1472-6874/14/38RESEARCH ARTICLE Open AccessThe effect of physical activity and body mass
index on menopausal symptoms in Turkish
women: a cross-sectional study in primary care
Makbule Neslisah Tan1*, Mehtap Kartal2 and Dilek Guldal2Abstract
Background: Considering the fact that, due to recent evidence, many women no longer prefer hormone
replacement therapy, it is especially important to develop intervention options to alleviate menopausal symptoms.
Although there is conflicting evidence concerning effectiveness, there is an indication that physical activity and
weight control may be useful for alleviating symptoms. The aim of this study was to investigate the effect of
physical activity and body mass index on menopausal symptoms among menopausal women in Turkey.
Methods: 305 women between the ages of 45 and 60 who visited the health center for various reasons were
recruited into this cross-sectional study. Menopausal women, who visited one of five family physicians working in
the same area, were included in the analyses. The Menopause Rating Scale, International Physical Activity
Questionnaire and a generic medical and socio-demographic information questionnaire were used.
Results: Women who were physically active had lower total menopausal (p < 0.001), somato-vegetative (p = 0.004),
psychological (p = 0.002), and urogenital (p < 0.001) symptom scores than women who were less active. No
differences in vasomotor symptoms were recorded related to physical activity level; significant differences were
found for most menopausal symptoms, including sleep (p = 0.009) and sexual (p = 0.043) problems, joint and muscular
discomfort (p < 0.001) and vaginal dryness (p = 0.016). BMI was not associated with total menopausal symptoms and
with the subscales, excluding depressive mood (p = 0.009). A significant increasing trend in the rate of depressive mood
was observed from normal through overweight to obese participants. The mean scores of the total menopausal
symptoms were lower among the participants who were well educated, currently working and without chronic
diseases.
Conclusions: Physical activity may play an important role in alleviating menopausal symptoms. As part of
preventive medicine, primary care physicians should also stress lifestyle changes, including physical activity, to
manage menopausal symptoms.
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The menopause is a significant event in most women’s
lives and is related to ovarian failure and follicular atresia.
It is characterized by the loss of ovarian function following
the reduction in the secretion of estrogen, permanent ces-
sation of menstruation and the loss of reproductive ability.
It affects women’s health in biological, psychological and
social aspects.* Correspondence: drnesli293@hotmail.com
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reproduction in any medium, provided the orMenopause can lead to a wide range of symptoms in-
cluding hot flashes, night sweats, sleeping problems, emo-
tional and cognitive symptoms, irritability, anxiety, vaginal
itching and dryness, and urinary symptoms. Reported hot
flushes rates for perimenopausal women ranged from 40
to 60% [1]. The prevalence of vaginal atrophy in the early
stages of the menopause increases as a woman advances
through the postmenopausal years [2].
Although the nature and prevalence of menopausal
symptoms are similar for most women, there are variations
across and within cultures which are due to differences. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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perception of individuals [3]. Menopausal symptoms
may become problem not for only women, but also for
their families, colleagues and communities. For this rea-
son, clinicians who provide care during the menopause,
have a significant opportunity for the provision of prevent-
ive medicine [4]. To fully benefit from this opportunity,
physicians should be equipped with the means to alleviate
the symptoms of the menopause.
The Global Consensus Statement on Menopausal Hor-
mone Therapy’s recommendations in November 2012 [5]
states, HRT is the most effective treatment for vasomotor
symptoms and urogenital atrophy, but it has a complex
pattern of risks and benefits. Current international con-
sensus suggest that the hormonal treatment of menopause
should be individualized and that the lowest dose of estro-
gen providing relief should be used for the shortest period
of time in menopausal women. However, women may
choose not to use hormone therapy because of possible
adverse effects. While many women are now seeking alter-
natives, attention is increasingly directed toward non-
hormonal approaches such as lifestyle changes to manage
symptoms. There are promising results in this aspect as a
result of lifestyle changes. The benefits of physical activity
and weight control on health and wellbeing are well-
known; however, the information concerning the explan-
ation of the relationship between lifestyle changes and
menopausal symptoms is very limited.
Evidence from studies concerning the effects of phys-
ical activity and exercise on vasomotor and other meno-
pausal symptoms is conflicting. There are studies stating
that physically active women have fewer menopausal
complaints [6-9], or vice versa [10]. Despite the fact that
many studies do not support a relation between physical
activity and vasomotor symptoms [7,11-14], a recent
study in Brasil, indicated that most of the women with
no hot flashes were observed to be very active [9]. There
are also studies indicating no sufficient evidence to de-
termine the effectiveness of exercise as a treatment for
vasomotor symptoms [15,16]. But also, Aiello et al. re-
ported that the intervention group who underwent phys-
ical exercise experienced a significant increase in the
severity of hot flashes [15]. A recent study suggested
that moderate aerobic exercise decreases hot flashes;
however, in women with lower fitness levels, more daily
moderate physical activity leads to more self-reported
symptoms [17].
There are conflicting results related to the effect of body
mass index on menopausal symptoms, especially hot
flashes. Several studies show that BMI is the main deter-
minant of endogenous estrogen levels. In addition, it ap-
pears that estradiol (E1) and estrone (E2) are at higher
levels among obese women than women within the nor-
mal weight range. Some studies demonstrate the fact thatfewer vasomotor symptoms occur in obese women as
compared to non-obese women [7,18]. In contrast, Klinga
et al. reported that E1 and E2 levels decrease earlier in
obese women as compared to non-obese women [19].
In addition, with regard to recent evidence, the impact
of body mass index (BMI) and physical activity on meno-
pausal symptoms is still unclear. The relationship between
menopausal symptoms with physical activity and BMI
may differ depending on the specific symptom and socio-
demographic factors may have an effect on the symptoms.
Most studies of menopause to date have been based either
on Euro-American populations or far away from Turkey.
To our knowledge, the effect of physical activity and body
mass index on menopausal symptoms and associated
sociodemographic characteristics have not been studied
in Turkey. The objective of this study was to determine
the effects of physical activity and BMI on menopausal
symptoms in addition to sociodemographic factors in-
fluencing menopausal symptoms of Turkish women
aged 45–60 years.
Methods
This cross-sectional study was performed in primary
care, between August and October 2009, in a semi-
urban area of Bornova, a district of Izmir, Turkey. Meno-
pausal women, who visited one of five family physicians
who were working in the same area, were included in
the analyses.
Study sample and criteria
305 menopausal women between the ages of 45–60 who
consulted the health center for any reason were recruited
into this cross-sectional study. Women were asked ques-
tions related to their menstrual cycles in order to include
appropriate participants who were in menopausal transi-
tion, either perimenopausal or postmenopausal period.
Concerning menopausal status, definitions were defined
according to the Stages of Reproductive Aging Workshop
(STRAW) [20]: perimenopausal (change in menstrual cycle
length of longer than 7 days/≥60 days amenorrhea/≥2
skipped cycles in the last 12 months) and postmenopausal
(no more menses in the last 12 months). Exclusion criteria
included: pregnancy or breastfeeding, hysterectomy with
intact ovary, chronic irregular menstruation, use of hor-
monal medication in the last 3 months or the inability to
complete the questionnaire. The present study was ap-
proved by the Dokuz Eylul University Medical Faculty
Ethics Committee. Written informed consent for partici-
pation in the study was obtained from participants.
Instrumentation and data collection
The study was described to the participants. Data were
collected via face-to-face interviews. The demographic
data collected in this study included socio-demographic
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and general health related (smoking, chronic disease, HRT
usage) factors. Participants were asked to complete the
Menopause Rating Scale (MRS) and International Physical
Activity Questionnaire (IPAQ).
The Menopause Rating Scale-MRS
MRS was developed in 2000 by Heinmann et al. [21].
The Turkish version of MRS has been validated by Gürkan
et al. in 2005 (the Cronbach α = 0.84) [22].
The MRS is a Likert-type scale which is composed of 11
items assessing menopausal symptoms divided into three
subscales: somato-vegetative, psychological and urogenital.
Each item is graded from 0 (not present) to 4 (1 = mild;
2 = moderate; 3 = severe; 4 = very severe). The total and
psychological, somato-vegetative and urogenital subscale
MRS scores that can be obtained at a minimum and max-
imum are 0–44; 0–16; 0–16; 0–12 respectively, and are
graded according to the severity of symptoms as: not
present, mild, moderate and severe. While the increase in
the total score of the scale indicates an increase in the se-
verity of the symptoms, a decreasing degree of severity of
symptoms means an improvement of health-related Qual-
ity of Life in aging women [23].
International Physical Activity Questionnaire-IPAQ
The IPAQ was developed by the International Group for
Consensus of Physical Activity Measurements and the
Turkish version was validated by Öztürk (Test–retest reli-
ability = 0.69) [24]. The IPAQ-short version, which in-
cludes seven items, is used to measure the frequency and
duration of vigorous intensity, moderate-intensity, and
walking-level physical activity for young and middle-aged
adults (15–69 years). To calculate the weekly physical
activity (MET-minute/ week), the number of minutes
per week dedicated to each activity is multiplied by the
specific MET score for that activity. The IPAQ sitting
question is an additional indicator variable of time spent
in sedentary activity and is not included as part of any
summary score of physical activity [25]. Data from the
questionnaire were gathered for each item (walking,
moderate intensity, vigorous intensity) to estimate the
total amount of time spent in physical activity per week.
Three levels of physical activity were proposed at the
end: low (no activity is reported or some activity is re-
ported but not enough to meet categories moderate and
high), moderate and high [24].
Body mass index-BMI
Height and weight were measured in light clothing and
without shoes, using standardized instruments (Mewa
Gmbtl/Schwerin-M318800). BMI was defined as weight
in kilograms divided by the square of height in meters.
The classification determined by the World HealthOrganization (WHO) was used to classify the participants
accordingly [26].
Statistical analysis
Data were analyzed using the SPSS software (version 15.0)
package program. For descriptive and categorical vari-
ables, data were expressed as frequency and percent dis-
tribution; and continuous variables were presented as
means ± standard deviation. In comparative analyses,
Chi-square and Fisher’s exact test were used to compare
categorical data. As normality assumptions were not
satisfied for continuous variables they were analyzed by
nonparametric methods as Mann Whitney-U, Kruskal
Wallis, and Spearman’s correlation tests. Tukey was ap-
plied for multiple comparisons in post-hoc-tests. A p
value less than 0.05 was considered statistically significant.
Results
The demographic and health-related characteristics of
the study population (n = 305) are reported in Table 1.
The mean age was 52.1 ± 4.3 years. Based on the scores
of IPAQ, 173 (56.7%) women were classified as having
low level of physical activity. The mean BMI was deter-
mined 31.9 ± 5.8 (minimum: 16.0, maximum: 56.3).
The mean somato-vegetative, psychological and urogeni-
tal subscale and total MRS scores were 4.6 ± 3.2, 4.7 ± 3.5,
2.9 ± 2.3 and 12.2 ± 7.2, respectively. The mean subscale
and total MRS scores in relation to sociodemographic and
health-related characteristics are reported in Table 2. The
mean scores of total MRS score as well as each subscale
of the MRS was determined to be significantly lower in
women whose educational levels were above primary
than primary school and women with no history of
chronic disease. Somato-vegetative mean scores were
found to be higher in non-working women than those
retired. The MRS total scores were also higher in non-
working participants. Urogenital subscale mean scores
were found to be much higher in married women than
women who were single. In women who have a history
of HRT use, somato-vegetative subscale scores were
found to be significantly higher compared to those who
have never used HRT (p = 0.047). No other relation was
observed between the MRS scores and other sociode-
mographic and health-related characteristics.
According to the IPAQ, the mean energy consumption
per week was 1205.2 ± 1639.9 MET-min/week. There was
a significant relationship between the level of physical ac-
tivity and the mean scores of total and all MRS subscales.
Women with low levels of physical activity had higher
scores in all MRS domains than those with moderate and
high levels of physical activity (Table 2). There were nega-
tive and significant correlations between total MRS scores
(r =−0.205; p < 0.01), somato-vegetative (r =−0.131; p < 0.05),
psychological (r =−0.176; p < 0.01) and urogenital (r =−0.189;
Table 1 Sociodemographic and health-related characteris-
tics (n = 305)
n % Mean ± SD (Range)








Primary school 212 69.5










Chronic disease Yes 178 58.4
No 127 41.6
Smoking status Ex/Current 109 35.7
Never 196 64.3
HRT usage Ex/Current 62 20.3
Never 243 79.7
Sitting time 376.7 ± 111.9 (60–780)





≤24.9 27 8.8 31.9 ± 5.8 (16.0–56.3)
25–29.9 84 27.5
≥30 194 63.6
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of the women. These variables were also compared with
demographic and health related factors (Table 3).
The median reported sitting time was 360 minutes/day,
with an interquartile range of 300–420 minutes. There
were weak but significant correlations between the time
spent sitting on a weekday in the last 7 days and BMI
(r = 0.119; p < 0.01 ), total physical activity score(r = −0.347,
p < 0.01), psychological subscale (r = 0.124, p < 0.05) and
total MRS score(r = 0.126, p < 0.05) (Table 3).
Table 4 shows the frequency of the 11 symptoms
assessed by the MRS according to physical activity level
and body mass index. The three most frequently re-
ported symptoms were: Physical and mental exhaustion
(76.1%), sexual problems (71.8%), and hot flashes and
sweating (70.5%). A significant decreasing trend in the
rate of both the sleep problems (p = 0.009) and indices
of joint pain (p = 0.001) was observed to correspond to
the progression in the level of physical activity; same as
the urogenital symptoms (Sexual problems p = 0.043,Dryness of vagina p = 0.016), with the exception of blad-
der problems. There were no other relationships in
terms of other subscale scores and physical activity level
(p > 0.05) (Table 4). In general terms, the present study
did not find any significant relationship between BMI
and total MRS and subscale scores (Tables 2 and 3).
There were no significant differences between BMI
groups according to all MRS subscales except, depressive
mood (p = 0.009) within the psychological symptoms. A
significant increasing trend in the rate of depressive
mood was observed from normal through overweight to
obese participants (Table 4).
Discussion
The MRS is a scale which is widely used to assess the
symptoms of the menopause. The present study illus-
trates the fact that the mean MRS total and subscale
scores were lower than in a multinational study [21]. In
a previous study in Korea, it was determined that the
scores obtained were lower than the mean scores of
North and Latin America [27]. In our study, the results
were higher than the mean scores of Europe, Latin
America and North America [23]. This suggests that cul-
tural differences affect the severity of menopausal symp-
toms. Dennerstein indicated that menopausal symptoms
tend to vary from culture to culture. Women in North
America and Europe were found more likely to experi-
ence severe climacteric symptoms compared to women
in Asian countries [28]. One previous study has sug-
gested that in Asian countries, women play a significant
role in society with advancing age; they become eligible
to participate in religious ceremonies and because they
accept menopausal symptoms as inevitable changes
which are to be experienced, they are thus able to adapt
in a short time and with a positive manner [29].
Although studies show a decrease in menopausal
symptoms going eastwards, in our study, menopausal
symptoms were observed to be above the average of
western countries. Some women consider changes dur-
ing the climacteric period to be a problem and seek
treatment, while others are relatively unaffected by any
occurring changes and therefore do not consider them
to be a problem. Uncu et al. suggested that women who
approach the menopause as a pathological period have
more menopausal complaints. With increasing levels of
education, a more positive perception of menopause has
been reported for Turkish women [30,31]. In this study,
the fact that the menopausal symptom scores are higher
than other studies may be due to the overall lower level
of education of the participants.
There are many studies investigating the relationship
between menopausal symptoms and the factors affecting
these symptoms. Similarly, in this study, depending on
Table 2 Sociodemographic and health-related characteristics and comparisons of means of total and subscale scores
Somato-vegetative* Psychological* Urogenital* Total*
MRS sores 4.6 ± 3.2 4.7 ± 3.5 2.9 ± 2.3 12.2 ± 7.2
Age
45–50 4.8 ± 3.2 5.0 ± 3.5 2.9 ± 2.4 12.6 ± 7.1
51–55 4.7 ± 3.3 4.6 ± 3.6 2.9 ± 2.2 12.3 ± 7.4
56–60 4.1 ± 2.9 4.3 ± 3.2 3.0 ± 2.4 11.4 ± 7.1
p-values 0.582 0.365 0.956 0.490
Educational level
No formal education 4.4 ± 3.0 4.7 ± 3.5 2.5 ± 2.0 11.6 ± 6.1
Primary school 5.0 ± 3.3 4.9 ± 3.5 3.2 ± 2.3 13.1 ± 7.5
Above primary 3.2 ± 2.4 3.5 ± 2.9 2.2 ± 2.3 9.0 ± 5.9
p-values 0.002 0.031 0.007 0.001
Employment status
Working 3.8 ± 2.2 3.9 ± 3.6 2.5 ± 2.3 10.2 ± 6.7
Non-working 5.1 ± 3.4 5.0 ± 3.4 3.1 ± 2.4 13.1 ± 7.5
Retired 4.0 ± 2.9 4.4 ± 3.4 2.8 ± 2.2 11.2 ± 6.7
p-values 0.026 0.094 0.473 0.039
Marital status
Married 4.6 ± 3.1 4.6 ± 3.5 3.2 ± 2.3 12.4 ± 7.2
Divorced/Separated, widowed, single 4.8 ± 3.7 5.1 ± 3.3 1.3 ± 1.4 11.1 ± 7.0
p-values 0.732 0.278 <0.001 0.464
Chronic disease
Yes 5.0 ± 3.3 5.1 ± 3.5 3.2 ± 2.3 13.3 ± 7.4
No 4.0 ± 2.8 4.1 ± 3.3 2.6 ± 2.2 10.7 ± 6.6
p-values 0.016 0.005 0.034 0.002
Smoking status
Ex/Current 5.1 ± 3.5 5.1 ± 3.6 2.9 ± 2.1 13.1 ± 7.5
Never 4.3 ± 2.9 4.5 ± 3.3 3.0 ± 2.4 11.7 ± 7.0
p-values 0.089 0.144 0.919 0.109
HRT usage
Ex/Current 5.4 ± 3.5 5.1 ± 3.6 3.2 ± 2.3 13.7 ± 7.7
Never 4.4 ± 3.1 4.6 ± 3.4 2.9 ± 2.3 11.8 ± 7.0
p-values 0.047 0.299 0.236 0.118
Physical activity level
Low 5.1 ± 3.2 5.1 ± 3.4 3.4 ± 2.4 13.6 ± 7.4
Moderate 4.1 ± 3.1 4.3 ± 3.5 2.3 ± 2.0 10.8 ± 6.6
High 3.3 ± 2.6 2.8 ± 3.1 2.0 ± 1.8 8.1 ± 6.5
p-values 0.004 0.002 <0.001 <0.001
Body mass index
≤24,9 4.9 ± 3.9 5.2 ± 4.2 2.4 ± 2.7 12.4 ± 8.7
25–29,9 4.7 ± 3.1 4.6 ± 3.6 3.0 ± 2.3 12.2 ± 7.3
≥30 4.5 ± 3.1 4.7 ± 3.3 3.0 ± 2.2 12.2 ± 7.0
p-values 0.848 0.831 0.181 0.955
*Data are expressed as means ± standard deviation.
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Table 3 Correlations between sociodemographic and health-related characteristics and total and subscale scores of
MRS
1 2 3 4 5 6 7 8 9 10 11 12 13 14
1 Age - −0.098 −0.052 0.163† 0.217† −0.244† −0.060 0.217† −0.004 0.074 −0.038 −0.044 0.013 −0.041
2 Education - 0.392† −0.090 0.088 −0.042 −0.017 −0.155† 0.086 −0.159† −0.121* −0.105 −0.070 −0.126*
3 Employment status - −0.098 −0.150† −0.055 −0.052 −0.077 0.077 −0.153† −0.150† −0.104 −0.041 −0.126*
4 Marital status - 0.009 0.000 0.036 −0.013 −0.032 0.025 0.020 0.062 −0.313† −0.042
5 Chronic disease - 0.019 0.096 0.180† −0.130* 0.093 0.138* 0.160† 0.122* 0.179†
6 Smoking status - 0.003 −0.083 0.155† −0.071 0.097 0.084 0.006 0.092
7 HRT - 0.147* 0.056 −0.084 0.114* 0.060 0.068 0.090
8 BMI - −0.185† 0.119† 0.049 0.035 0.111 0.074
9 IPAQ - −0.347† −0.131* −0.176† −0.189† −0.205†
10 Sitting - 0.102 0.124* 0.090 0.126*
11 Somato-vegetative - 0.531† 0.368† 0.821†
12 Psychological - 0.378† 0.837†
13 Urogenital - 0.656†
14 Total MRS -
*p < 0.05 †p < 0.01.
Tan et al. BMC Women's Health 2014, 14:38 Page 6 of 9
http://www.biomedcentral.com/1472-6874/14/38socio-demographic and health-related variables, several
variations of menopausal symptoms were reported.
Menopausal symptoms were experienced less by women
who were at least high school graduates, working, with
no history of chronic disease and a high level of physical
activity. Previous studies have indicated a negative rela-
tionship between menopausal symptoms and educational
levels [32-34]. This could be because having accurate
and reliable knowledge about the period of menopause
is facilitated with the increase in the level of education.Table 4 Frequency of menopausal symptoms as assessed by t
and body mass index
Physical activity lev
MRS Low Moderate H
Somato-vegetative
Hot flashes, sweating (n = 215) 123 (71.1) 78 (67.8) 14
Heart discomfort (n = 129) 77 (44.5) 46 (40.0) 6
Sleep problems (n = 160) 103 (59.5) 52 (45.2) 5
Joint and muscular discomfort (n = 201) 129 (74.6) 65 (56.5) 7
Psychological
Depressive mood (n = 202) 120 (69.4) 72 (62.6) 10
Irritability (n = 203) 121 (69.9) 75 (65.2) 7
Anxiety (n = 136) 85 (49.1) 47 (40.9) 4
Physical and mental exhaustion (n = 232) 138 (79.8) 83 (72.2) 11
Urogenital
Sexual problems (n = 219) 134 (77.5) 74 (64.3) 11
Bladder problems (n = 116) 75 (43.4) 34 (29.6) 7
Dryness of vagina (n = 101) 66 (38.2) 34 (29.6) 1
aColumn% for each row showing the number of women having symptoms.The study indicated that somato-vegetative symptoms
in working or retired women are fewer than those with
no work experience [27,35,36]. There was a significant
difference in favor of working women in terms of general
adjustment, social adjustment, and self-actualization [37].
Thus, having more opportunities to prove themselves may
have a positive effect on the psychological status of work-
ing women.
As indicated in a previous study among a cohort of
postmenopausal women, although sexually inactive womenhe MRS in total and according to physical activity level
el n (%)a Body mass index n (%)a
igh p-values ≤24,9 25-29,9 ≥30 p-values
(82.4) 0.455 18 (66.7) 61 (72.6) 136 (70.1) 0.824
(35.3) 0.626 17 (63.0) 36 (42.9) 76 (39.2) 0.064
(29.4) 0.009 13 (48.1) 51 (60.7) 96 (49.5) 0.203
(41.2) 0.001 15 (55.6) 50 (59.5) 136 (70.1) 0.115
(58.8) 0.396 12 (44.4) 51 (60.7) 139 (71.6) 0.009
(41.2) 0.052 17 (63.0) 55 (65.5) 131 (67.5) 0.868
(23.5) 0.076 12 (44.4) 35 (41.7) 89 (45.9) 0.810
(64.7) 0.177 21 (77.8) 68 (81.0) 143 (73.7) 0.420
(64.7) 0.043 15 (55.6) 61 (72.6) 143 (73.7) 0.142
(41.2) 0.059 7 (25.9) 29 (34.5) 80 (41.2) 0.227
(5.9) 0.016 5 (18.5) 35 (41.7) 61 (31.4) 0.060
Tan et al. BMC Women's Health 2014, 14:38 Page 7 of 9
http://www.biomedcentral.com/1472-6874/14/38scored significantly higher in another study, marital status
was not associated with urogenital symptoms, [27,38]. In
our study, fewer urogenital symptoms were observed in
the sexually inactive women. However, taking into con-
sideration the cultural constraints in Turkey, we should
not overlook the fact that people might sometimes not
answer questions accurately in order to avoid culturally
determined negative perceptions.
In this study, as compatible with existing studies,
menopausal symptoms were observed more commonly
in women with a history of chronic disease [39,40]. In
contrast to the substantial majority of published studies
supporting the finding that active cigarette smoking in-
creases the risk for vasomotor symptoms [11,41-44]; we
did not find an increased number of menopausal symp-
toms in smokers. The present study found that the
somato-vegetative scores of women who used HRT were
significantly higher compared to those who did not.
These subjects’ HRT requirements suggested that they
already had severe symptoms. Similarly; it was found in
a cohort of 202,638 postmenopausal women, past hor-
mone therapy users who had discontinued treatment were
more likely to have hot flushes and night sweats [45].
For women with menopausal symptoms who aim for
healthy living in the long term, regular exercise and
keeping BMI within the normal range are the necessary
lifestyle change recommendations [46].
To our knowledge, exercise and physical activity have
benefits for a healthy life but also offer conflicting evi-
dence for roles in menopausal symptoms. This study
found a significant decrease in the mean scores of all MRS
domains of women as their physical activity increase. Re-
cently, similar results were observed in a Brazilian study
of 370 women aged 40–65 years [9].
The hypothesis that physical activity may protect against
vasomotor symptoms is based on the effects on the hypo-
thalamic β-endorphin system: lowered β-endorphin may
be a mechanism underlying vasomotor pathogenesis, and
physical activity elevates β-endorphin. An alternative the-
ory is that physical activity could provoke vasomotor
symptoms in women who have a narrowed thermo-
neutral zone [11]. Physical activity increases body core
temperature and might thus stimulate more hot flushes,
especially when performed at high exercise intensities. In
this study, no significant relationship between physical ac-
tivity and vasomotor symptoms was observed. Because of
the conflicting results, there is considerable need for inter-
vention studies which can determine the effect of physical
activity and assess the effect of exercise intensity on vaso-
motor symptoms.
The present study showed that the incidence of joint
and muscular discomfort, sexual problems and vaginal
dryness was higher in women with reported lower levels
of physical activity. Some studies reported that fewersomatic symptoms were observed in physically active
women compared with sedentary women [6,7,9,47,48].
Suling et al. found that women who were physically ac-
tive were less likely to experience vaginal dryness and
loss of sexual desire [14]. However, it is not clear how
physical activity affects sexual health.
Knowledge about the influence of physical activity on
psychological symptoms is limited to theories. Some pub-
lished studies have reported that physical activity reduces
psychological symptoms by causing an increase in the
level of β-endorphin [14,49,50]. Previously, a cohort
study in Australia reported that the psychological
symptoms of the menopause had no association with
physical activity [47].
Among middle aged women, a mid-to-low intensity of
exercise participation is higher [51], whereas in the pres-
ence of high-intensity exercise β-endorphin is more likely
to occur [50]. The relationship between physical activity
and menopausal symptoms may also change depending
on the intensity of the physical activity.
Referring to the relationship between BMI and vaso-
motor symptoms, some studies reported that higher BMI
was associated with increased vasomotor symptoms; while
others like ours, have shown no association [7,13,52,53]. A
high BMI potentially implies a greater amount of adipose
tissue, and this may alleviate the symptoms by converting
adrenal androgens to estrogens. However, in this case, ex-
ercise may increase vasomotor symptoms by reducing adi-
pose tissue.
In this study, our finding of little or no relationship be-
tween BMI and the menopausal symptoms may be asso-
ciated with endogenous estrogen levels in women with
different body size. In addition, fluctuations in estradiol
level which are associated with weight gain may affect
symptoms.
This is a cross-sectional study and it may not provide
definitive information about cause-and-effect relation-
ships. Therefore, as a limitation of our study, we can’t
fully determine whether pre-existing physical activity
and BMI indicate various menopausal symptoms.
Conclusions
The menopause is a period of life, and therefore should
not be viewed as a disease. However, the changes associ-
ated with the menopause affect women in different levels
and this induces some women to seek treatment. Al-
though HRT remains the most effective treatment for
vasomotor symptoms, many women, based on recent evi-
dence, no longer prefer hormone replacement therapy
and are now seeking alternatives. Therefore, during this
period, regular physical activity can be recommended as
effective lifestyle change. In conclusion, the present study
found that although somato-vegetative, psychological and
urogenital symptoms were all alleviated by physical activity,
Tan et al. BMC Women's Health 2014, 14:38 Page 8 of 9
http://www.biomedcentral.com/1472-6874/14/38they were not related to BMI. These results can be prom-
ising for women who do not want to use pharmacological
agents in the treatment of menopausal symptoms. Further
intervention studies are needed to investigate the effect of
physical activity and BMI on menopausal symptoms.
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